SCHEMBL17849240

SCHEMBL17849240

N=C(Nc1ccccc1)c1c(NC2CCCC2)cc[nH]c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK1 P23458 8/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
EPHX2 P34913 2/20 0.42
EPHX1 P07099 1/20 0.42
RAB9A P51151 1/20 0.42
MAPT P10636 2/20 0.40
EGFR P00533 2/20 0.40
JAK2 O60674 5/20 0.38
HPGD P15428 3/20 0.38
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
OPRM1 P35372 1/20 0.37
OPRD1 P41143 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
LMNA P02545 3/20 0.37
POLB P06746 1/20 0.37
TYK2 P29597 2/20 0.36
JAK3 P52333 2/20 0.36
PRKAA1 Q13131 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16623602 0.88 JAK1 (0.37) JAK1EPHX1RAB9AEGFRJAK2
SCHEMBL20246056 0.87 HCAR3 (0.40) JAK1SMN1; SMN2EPHX2EPHX1RAB9A
SCHEMBL20246042 0.87 RAB9A (0.46) JAK1SMN1; SMN2EPHX1RAB9AEGFR
SCHEMBL16623571 0.86 JAK1 (0.34) JAK1SMN1; SMN2EPHX2EPHX1RAB9A
SCHEMBL20246309 0.85 EPHX1 (0.47) JAK1EPHX2EPHX1RAB9AMAPT
SCHEMBL20246326 0.84 LMNA (0.46) JAK1SMN1; SMN2EPHX2EPHX1MAPT
SCHEMBL20246553 0.84 JAK1 (0.37) JAK1EPHX2EPHX1RAB9AMAPT
SCHEMBL20246179 0.84 BRD4 (0.44) JAK1EPHX2JAK2HPGDALDH1A1
SCHEMBL16623521 0.84 JAK1 (0.39) JAK1RAB9AMAPTJAK2KDM4E
SCHEMBL20246136 0.83 SMN1; SMN2 (0.40) JAK1SMN1; SMN2JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed